GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » WuXi XDC Cayman Inc (HKSE:02268) » Definitions » Other Financing

WuXi XDC Cayman (HKSE:02268) Other Financing : HK$3,933 Mil (TTM As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is WuXi XDC Cayman Other Financing?

WuXi XDC Cayman's Other Financing for the six months ended in Jun. 2024 was HK$-3 Mil.

WuXi XDC Cayman's Other Financing for the trailing twelve months (TTM) ended in Jun. 2024 was HK$3,933 Mil.

WuXi XDC Cayman Other Financing Historical Data

The historical data trend for WuXi XDC Cayman's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WuXi XDC Cayman Other Financing Chart

WuXi XDC Cayman Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Other Financing
- - -0.36 -6.48

WuXi XDC Cayman Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Other Financing Get a 7-Day Free Trial -0.23 -0.15 -0.28 3,935.74 -2.62

WuXi XDC Cayman Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$3,933 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

WuXi XDC Cayman Other Financing Related Terms

Thank you for viewing the detailed overview of WuXi XDC Cayman's Other Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

WuXi XDC Cayman Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » WuXi XDC Cayman Inc (HKSE:02268) » Definitions » Other Financing
Comparable Companies
Traded in Other Exchanges
L74:Germany
Address
No. 11 Xinhui Ring Road, Xinwu, Jiangsu, Wuxi, CHN
Website
https://www.wuxixdc.com
WuXi XDC Cayman Inc is a leading CRDMO focused on the global ADC and broader bioconjugate market and the only one dedicated to providing integrated and end-to-end services. Leveraging expertise in both biologics and small molecules, It offers interdisciplinary and comprehensive services, covering bioconjugate discovery, research, development and manufacturing. The company provides these services from proximately located, state-of-the-art laboratories and manufacturing facilities, leading to the significant reduction of development timeline and costs. As a fully integrated one-stop bioconjugate discovery, development and manufacturing platform, its mission is to continuously enhance its platform, and propel and transform the development of the bioconjugate industry.
Executives
Wuxi Biologics (cayman) Inc. 2101 Beneficial owner
Wuxi Apptec Co., Ltd.
Shang Hai He Quan Yao Ye Gu Fen You Xian Gong Si
He Quan Yao Ye Xiang Gang Tou Zi You Xian Gong Si
Shang Hai Yao Ming Kang De Xin Yao Kai Fa You Xian Gong Si

WuXi XDC Cayman Headlines

No Headlines